Targeting BRAF‐Mutant Non‐Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy

Non‐small cell lung cancer (NSCLC) remains the leading cause of cancer‐related deaths globally. However, the identification of oncogenic driver alterations involved in the initiation and maintenance of NSCLC, such as epidermal growth factor receptor mutations and anaplastic lymphoma kinase transloca...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Baik, Christina S., Myall, Nathaniel J., Wakelee, Heather A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2017
Konular:
Academia‐Pharma Intersect: Lung Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5507646/
https://ncbi.nlm.nih.gov/pubmed/28487464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0458
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller